Search Results

You are looking at 81 - 90 of 1,029 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

Searching for Survivor-Specific Services at NCI-Designated Comprehensive Cancer Centers: A Qualitative Assessment

Betsy Rolland and Jordan Eschler

increasing survivorship, NCI-designated Comprehensive Cancer Centers (CCCs) will be called on to take the lead for community providers and to act as sources of information for survivors, their caregivers, and clinicians as they navigate the next phase of care

Full access

Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study

Elizabeth A. Rohan, Beth Slotman, Amy DeGroff, Kerry Grace Morrissey, Jennifer Murillo, and Paul Schroy

increasing patient completion of cancer screening and reducing disparities among the medically underserved. 9 – 17 Generally, patient navigators (herein referred to as “navigators”) are either nonclinical members of the community or healthcare professionals

Full access

NCCN Policy Summit: Reducing the Cancer Burden Through Prevention and Early Detection

Lindsey Bandini, Alyssa Schatz, Victoria Hood, Nikia Clark, Michael J. Hall, and Robert W. Carlson

From 2015 to 2020, the CRCCP reached >1.3 million patients. The initiative led by Project BAT works to identify social norms associated with tobacco use and assesses the accessibility of free or low-cost nicotine replacement therapy in their community

Full access

Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts

Thomas A. D’Amico, Lindsey A.M. Bandini, Alan Balch, Al B. Benson III, Stephen B. Edge, C. Lyn Fitzgerald, Robert J. Green, Wui-Jin Koh, Michael Kolodziej, Shaji Kumar, Neal J. Meropol, James L. Mohler, David Pfister, Ronald S. Walters, and Robert W. Carlson

patient advocacy, community oncology, and health information technology representatives, to review the existing quality landscape and identify contemporary, relevant cancer quality and outcomes measures by both reevaluating current validated measures and

Full access

Optimizing Systemic Therapy for Bladder Cancer

Sumanta K. Pal, Matthew I. Milowsky, and Elizabeth R. Plimack

within the urologic community that the 9% increase in disease-specific survival is of small magnitude. 24 Adjuvant Chemotherapy The NCCN Guidelines confer a category 2B recommendation (lower-level of evidence and consensus) for use of adjuvant

Full access

CLO19-055: Implementing Scalp Cooling: Considerations and Best Practice

Brittany Unthank, Lynne Laurence Brophy, Lindsey Radcliff, Heidi Basinger, and Sabrenna Bourque

satisfaction data will be disseminated. Conclusion: The oncology community is eager to provide patients with scalp cooling, but no literature to date has described the management aspects of implementation. This presentation will offer comprehensive

Full access

QIM119-120: Utilizing Technology to Identify Oncology Patients to Impact Patient Care

Brook Blackmore, Nicole Centers, and Troy Gifford

in a community health system is feasible and associated with multiple benefits. Increased navigator patient volumes and navigator productivity were observed. Navigator time spent with patients and physicians increased with a concurrent reduction in

Full access

Practice Patterns, Guideline-Based Treatments, Costs and Efficacy of Care, and Global Perspectives: A Call for Papers on Excellence in Cancer Care

Harold J. Burstein

in cancer care, from both academic and community perspectives. We are particularly seeking original research and insightful commentary on the best ways to use resources and improve outcomes for patients. Examples of such contributions might include

Full access

Creating An Adolescent and Young Adult Cancer Program: Lessons Learned From Pediatric and Adult Oncology Practice Bases

Damon Reed, Rebecca G. Block, and Rebecca Johnson

, creating dedicated patient care facilities, and educating the community about AYA oncology. Program development during the first 2 years addressed the most glaring unmet needs of AYAs treated in a pediatric hospital. Institutional approval was obtained to

Full access

Preliminary Report: The Development of the NCCN Comparative Therapeutic Index™ as a Clinical Evaluative Process for Existing Data in Oncology

Edward C. Li and Jessica DeMartino

community focus on cancer care, it is critical that the oncology community be actively involved in the development and implementation of processes at all levels. To address the knowledge gap problem with CER, consideration must be given to the current